香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而做出。 茲載列廈門吉宏科技股份有限公司於巨潮資訊網(www.cninfo.com.cn)刊登的公告 如下，僅供參閱。 承董事會命 廈門吉宏科技股份有限公司 執行董事兼總經理 莊浩女士 香港，2025年6月5日 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2603） （「本公司」） 於本公告日期，董事會成員包括(i)執行董事王亞朋先生、莊浩女士、張和平先生、 莊澍先生及陸它山先生，(ii)非執行董事廖生興先生，及(iii)獨立非執行董事張國 清博士、楊晨暉博士、薛永恒教授、韓建書先生及吳永蒨女士。 证券代码：002803 证券简称：吉宏股份 公告编号：2025-039 厦门吉宏科技股份有限公 ...

Core Viewpoint - Jihong Co., Ltd. has successfully listed on the Hong Kong Stock Exchange, becoming the first "A+H" cross-border social e-commerce stock, with a significant opening increase of 43% to HKD 11, reflecting market recognition of its dual-track leadership and AI-driven capabilities [1][4][2]. Group 1: Company Overview - Jihong Co., Ltd. was established in 2003 and initially focused on providing packaging solutions for fast-moving consumer goods. It has since expanded into cross-border social e-commerce, leveraging its experience in packaging to connect suppliers with consumers in Asia, Europe, and North America [6][11]. - The company operates two main business segments: ToC precision marketing cross-border social e-commerce and ToB comprehensive marketing design and packaging services, establishing a leading position in both sectors [6][11]. Group 2: Financial Performance - Jihong's cross-border social e-commerce business generated revenues of CNY 3.107 billion, CNY 4.257 billion, and CNY 3.366 billion from 2022 to 2024, accounting for approximately 60% of total revenue [11]. - The gross margin for the cross-border social e-commerce business exceeded 60% in 2023 and 2024, significantly higher than the industry average, indicating a successful "technology premium" model [11]. - In Q1 2025, Jihong achieved a revenue of CNY 1.477 billion, a year-on-year increase of 11.55%, with net profit rising by 57.97% to CNY 62.47 million [12]. Group 3: Technological Advancements - Jihong has developed the Giikin system, which integrates AI applications to optimize the entire business process from product selection to logistics, reducing the product selection cycle by 60% and increasing the accuracy of hit product predictions to 82% [7][8]. - The company has filed for 4 patents and 140 software copyrights related to its cross-border social e-commerce algorithms and software systems, showcasing its commitment to technological innovation [8]. Group 4: Market Position and Strategy - Jihong's cross-border e-commerce business is positioned in a rapidly growing market, with the Asian segment contributing over 80% of its revenue, allowing it to mitigate risks from trade policy fluctuations in Europe and the U.S. [17][18]. - The company plans to use the proceeds from its IPO to expand into Southeast Asia, Europe, and Latin America, capitalizing on the growth potential in these emerging markets [24][27]. Group 5: Packaging Business Growth - Jihong's paper packaging business has shown steady growth, with production increasing from 846.7 million square meters in 2022 to 1.026 billion square meters in 2024 [19]. - The company is actively developing biodegradable materials and lightweight structures to meet the growing demand for sustainable packaging solutions [19][20]. Group 6: Shareholder Returns - Jihong has a strong commitment to returning value to shareholders, with a cash dividend distribution plan announced for 2024, amounting to CNY 68.17 million [13]. - The company has also implemented a share buyback plan, reflecting its confidence in future business growth [13].

Core Viewpoint - The company, Xiamen Jihong Technology Co., Ltd. (吉宏股份), has successfully leveraged a social e-commerce model to expand its cross-border business, becoming a significant growth driver for the company [1][4]. Group 1: Company Overview - Xiamen Jihong Technology Co., Ltd. was officially listed on the Hong Kong Stock Exchange on May 27, with an opening price of HKD 11 per share, representing a 43.23% increase from the issue price, and a market capitalization exceeding HKD 5 billion [3][4]. - Established in 2003, the company initially focused on fast-moving consumer goods (FMCG) packaging, collaborating closely with well-known brands such as Yili and Luckin Coffee [4]. - The company has developed a one-stop packaging solution capability, providing comprehensive production processes in the paper-based FMCG packaging sector [4]. Group 2: Business Model and Growth Strategy - In 2017, the company identified the rapid increase in e-commerce penetration in Southeast Asia and innovatively adopted a social e-commerce model to expand its cross-border business [4]. - The company operates with a "data-driven, technology-enabled" approach, focusing on independent site models to offer diverse products and services, significantly reducing customer sourcing time and enhancing shopping experiences [4]. - The company has developed the Giikin system, powered by AI algorithms, to optimize the entire supply chain from product selection to logistics, successfully innovating its "goods find people" business model [4]. Group 3: Market Position and Industry Growth - As of now, the company has six brands, including SENADA BIKES, Veimia, Konciwa, and PETTENA, with products sold on e-commerce platforms and brand websites covering electric bicycles, underwear, sunshades, and pet supplies [5]. - The company ranks second among B2C export e-commerce companies in China with a market share of 1.3%, and first in the paper-based FMCG sales packaging sector with a market share of 1.2% [6]. - The paper-based FMCG sales packaging market in China is experiencing rapid growth, with the market size projected to increase from RMB 145.6 billion in 2020 to RMB 170.3 billion by 2024 [6]. - The Southeast Asian e-commerce market is recognized as the fastest-growing and most promising segment globally, positioning the company to benefit from ongoing market growth [6].

Core Viewpoint - The recent debut of Ji Hong Co., Ltd. (吉宏股份) on the Hong Kong Stock Exchange has seen a significant stock price surge, reflecting a strong market interest in A+H shares following the successful listings of other companies like CATL and Hengrui Medicine [1][5]. Group 1: Ji Hong Co., Ltd. (吉宏股份) - Ji Hong Co., Ltd. officially listed on the Hong Kong Stock Exchange on May 27, with its stock price increasing by over 60% at one point, closing with a gain of 48.70% [1][5]. - The company operates in cross-border social e-commerce and paper packaging for fast-moving consumer goods, ranking second in China's B2C export e-commerce market with a 1.3% market share [5]. - Ji Hong's total market capitalization is approximately 6.2 billion CNY, significantly lower than larger companies like CATL and Hengrui Medicine [5]. - The company reported a decline in revenue and net profit for 2024, with revenue expected to drop by 17.41% and net profit by 47.28% compared to the previous year [6]. - Ji Hong's H-shares were issued at a price of 7.68 HKD, which is nearly 50% lower than its A-share price of 14.09 CNY, indicating a substantial discount [11]. Group 2: Market Performance and Investor Sentiment - The recent trend of A+H shares has been positive, with Ji Hong's strong debut following the impressive performances of CATL and Hengrui Medicine, leading to heightened investor expectations for future A+H listings [1][5]. - Ji Hong's IPO attracted three cornerstone investors, raising approximately 20 million USD, which accounted for about 29.8% of the total shares issued [7]. - The IPO saw a subscription rate of 1.6 times for international placements and 49.4 times for public offerings in Hong Kong, triggering a reallocation of shares [8][9]. - Despite the strong debut, the overall subscription enthusiasm for Ji Hong was not particularly high, as indicated by the lower-than-expected demand compared to other popular Hong Kong stocks [11]. Group 3: Pei Ge Biomedical (派格生物医药) - In contrast to Ji Hong, Pei Ge Biomedical, which also debuted on May 27, experienced a disappointing performance, with its stock price dropping over 17% on the first day [3][13]. - Pei Ge's public offering saw a high subscription rate of 743.78 times, but the international offering was only 1.13 times, indicating a disparity in interest between retail and institutional investors [13][15]. - The company has faced challenges in its listing journey, having previously withdrawn its application for A-share listing in 2022 before successfully listing on the Hong Kong Stock Exchange in 2024 [16][17].

Core Viewpoint - The article discusses the contrasting performances of two newly listed companies on the Hong Kong Stock Exchange: Jihong Co., which saw a significant stock price increase, and Paige Biopharmaceuticals, which experienced a decline on its debut. Group 1: Jihong Co. Performance - Jihong Co. officially listed on the Hong Kong Stock Exchange on May 27, with its stock code being 02603.HK. The stock surged over 60% at opening and maintained a rise of 48.70% at the time of reporting [1][2]. - The company is a dual-driven enterprise with cross-border social e-commerce and paper packaging businesses, established in 2003. It ranked second in China's B2C export e-commerce with a market share of 1.3% and first in paper packaging sales with a market share of 1.2% [6]. - Jihong Co. had a total market capitalization of approximately 6.2 billion CNY (around 62 million USD) at the time of listing, which is relatively small compared to larger companies like Ningde Times [6]. - The company reported a decline in revenue and net profit for 2024, with revenue dropping by 17.41% to approximately 5.53 billion CNY and net profit decreasing by 47.28% to about 181.93 million CNY [8]. - The IPO attracted significant interest, with a subscription rate of 49.4 times for the public offering and 1.6 times for the international offering, leading to a total issuance of 67.91 million shares at a price of 7.68 HKD per share [9][10]. Group 2: Paige Biopharmaceuticals Performance - Paige Biopharmaceuticals also listed on May 27 but faced a disappointing debut, with its stock price dropping over 17% and reaching a maximum decline of 28% during trading [3][4]. - The company had a high public offering subscription rate of 743.78 times, but the international offering only saw a subscription rate of 1.13 times, indicating a disparity in interest between retail and institutional investors [15][17]. - Paige Biopharmaceuticals focuses on innovative therapies for chronic diseases, particularly in the metabolic disorder field, and has faced challenges in its path to listing, including a previous withdrawal of its A-share application [18][19]. - The company reported significant losses, with total losses of approximately 306 million CNY in 2022 and 279 million CNY in 2023, primarily due to research and development expenditures [19].

香 港 交 易 及 結 算 所 有 限 公 司、香 港 聯 合 交 易 所 有 限 公 司（「聯交所」）及 香 港 中 央 結 算 有 限 公 司（「香 港結算」）對 本 公 告 的 內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 會就本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本公告不會直接或間接於或向美國（包括美國的領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發或派發。本公告並不構成亦不屬於在美國境內或於任何其他司法管轄區購買或認購證券的 任何要約或招攬的一部分。本公告所述證券並無亦不會根據《1933年美國證券法》（經不時修訂）（「《美 國證券法》」）或美國任何州或其他司法管轄區的證券法登記。證券不得在美國境內提呈發售、出售、 質押或以其他方式轉讓，惟獲豁免遵守美國證券法登記規定及符合任何適用的州證券法則另作 別 論，或 除 非 符 合 美 國 證 券 法 項 下 的S規 例，否 則 不 得 在 美 國 境 外 提 呈 發 售、出 售、質 押 或 以 其 他方式轉讓。證券不會在美國公開發售。 本 ...

XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 董事會提名委員會實施細則 第一章 總 則 第一條 為規範公司領導人員產生，優化董事會組成，完善公司治理結構， 根 據《中 華 人 民 共 和 國 公 司 法》、《公 司 章 程》，參 考《上 市 公 司 治 理 準 則》《深 圳 證 券 交 易 所 股 票 上 市 規 則》《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》《深 圳 證 券 交 易 所上市公司自律監管指引第1號–主 板 上 市 公 司 規 範 運 作》及 其 他 有 關 規 定，公 司 特設立董事會提名委員會，並制定本實施細則。 第二條 董事會提名委員會是董事會按照股東大會決議設立的專門工作機 構，主 要 負 責 對 公 司 董 事 及 經 理 人 員 的 人 選、選 擇 標 準 和 程 序 進 行 選 擇 並 提 出 建議。 第二章 人員組成 第三條 提名委員會成員由三名董事組成，其中獨立非執行董事（即獨立董事） 應佔多數。 第四條 提 名 委 員 會 委 員 由 董 事 長、二 分 之 一 以 上 獨 立 ...

XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 王亞朋先生 （董事長） 莊浩女士 （總經理） 張和平先生 （副董事長兼副總經理） 莊澍先生 （副總經理） 陸它山先生 （聯席公司秘書） 非執行董事 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2603） （「本公司」） 董事名單與其角色和職能 本 公 司 董 事 會（「董事會」）成 員 載 列 如 下： 執行董事 廖生興先生 獨立非執行董事 張國清博士 楊晨暉博士 薛永恒教授 韓建書先生 吳永蒨女士 C =相關董事委員會的主席 M =相關董事委員會的成員 2025年5月27日 – 2 – 董事會設有四個委員會。下表載列該等委員會的成員詳情。 董事委員會 董 事 戰略委員會 審計委員會 薪酬與考核 委員會 提名委員會 王亞朋先生 C 莊浩女士 M 張和平先生 M 莊澍先生 M 陸它山先生 廖生興先生 張國清博士 C M 楊晨暉博士 M C 薛永恒教授 M 韓建書先生 M 吳永蒨女士 M C – 1 – 附註： ...

XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 董事會戰略委員會實施細則 第一章 總 則 第一條 為適應公司戰略發展需要，增強公司核心競爭能力，確定公司發展 規劃，健全投資決策程序，加強決策科學性，提高重大投資決策的效益和決策的 質量，完善公司治理結構，實現公司在經濟、社會及環境的協調統一及可持續發 展，積 極 踐 行 企 業 社 會 責 任，提 升 公 司 在 環 境、社 會 及 治 理（以 下 簡 稱「ESG」）方 面 的 風 險 控 制 能 力 和 價 值 創 造 能 力，根 據《中 華 人 民 共 和 國 公 司 法》《公 司 章 程》， 參 考《上 市 公 司 治 理 準 則》《深 圳 證 券 交 易 所 股 票 上 市 規 則》《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》《深 圳 證 券 交 易 所 上 市 公 司 自 律 監 管 指 引 第1號–主板上市公 司規範運作》及其他有關規定，公司特設立董事會戰略委員會，並制定本實施細則。 第四條 戰 略 委 員 會 委 員 由 董 事 長、二 分 之 一 以 ...

XIAMEN JIHONG CO., LTD 廈門吉宏科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 董事會審計委員會實施細則 第一章 總 則 第一條 為強化董事會決策功能，做到事前審計、專業審計，確保董事會對 經 理 層 的 有 效 監 督，完 善 公 司 治 理 結 構，根 據《中 華 人 民 共 和 國 公 司 法》《公 司 章 程》，參 考《上 市 公 司 治 理 準 則》《深 圳 證 券 交 易 所 股 票 上 市 規 則》《香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則》《深 圳 證 券 交 易 所 上 市 公 司 自 律 監 管 指 引 第1號–主板上 市 公 司 規 範 運 作》及 其 他 有 關 規 定，公 司 特 設 立 董 事 會 審 計 委 員 會，並 制 定 本 實 施細則。 第二條 董事會審計委員會是董事會按照股東大會決議設立的專門工作機 構，主要負責公司內、外部審計的溝通、監督和核查工作。 第二章 人員組成 第三條 審 計 委 員 會 成 員 由 三 名 非 執 行 董 事 組 成，且 不 能 為 在 上 市 公 司 擔 任 高 級 管 理 人 ...